The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...

Degrees Pharmaceuticals has entered into a clinical study agreement with the Icahn School of Medicine at Mount Sinai in the ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

UK-based Monument Therapeutics has joined forces with the Foundation for the National Institutes of Health (FNIH), US, to ...

A recently published study provides an incentive to explore what specific aspects of vegetarianism are protective.